Femara helps protect against return of breast cancer after completing Tamoxifen thera

[News]

Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.

More... (http://www.news-medical.net/?id=36087)